JP2025502240A5 - - Google Patents
Info
- Publication number
- JP2025502240A5 JP2025502240A5 JP2024541916A JP2024541916A JP2025502240A5 JP 2025502240 A5 JP2025502240 A5 JP 2025502240A5 JP 2024541916 A JP2024541916 A JP 2024541916A JP 2024541916 A JP2024541916 A JP 2024541916A JP 2025502240 A5 JP2025502240 A5 JP 2025502240A5
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethyl
- salt
- triazine
- amine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22150829 | 2022-01-11 | ||
| EP22150829.4 | 2022-01-11 | ||
| PCT/EP2023/050208 WO2023135057A1 (en) | 2022-01-11 | 2023-01-06 | Bicyclic triazine derivatives for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502240A JP2025502240A (ja) | 2025-01-24 |
| JP2025502240A5 true JP2025502240A5 (https=) | 2026-01-06 |
Family
ID=79927598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541916A Pending JP2025502240A (ja) | 2022-01-11 | 2023-01-06 | がんの治療のための二環式トリアジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250066370A1 (https=) |
| EP (1) | EP4463458A1 (https=) |
| JP (1) | JP2025502240A (https=) |
| KR (1) | KR20240134962A (https=) |
| CN (1) | CN118541372A (https=) |
| AU (1) | AU2023207765A1 (https=) |
| CA (1) | CA3246440A1 (https=) |
| IL (1) | IL313835A (https=) |
| WO (1) | WO2023135057A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021176045A1 (en) * | 2020-03-06 | 2021-09-10 | Bayer Aktiengesellschaft | Imidazotriazines acting on cancer via inhibition of cdk12 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011529072A (ja) | 2008-07-24 | 2011-12-01 | セラヴァンス， インコーポレーテッド | 二重作用血圧降下薬 |
| US8791162B2 (en) | 2011-02-14 | 2014-07-29 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
| MX2019012431A (es) | 2017-04-21 | 2020-08-03 | Ikena Oncology Inc | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. |
| TW202146416A (zh) | 2019-12-11 | 2021-12-16 | 德商拜耳廠股份有限公司 | 吡唑并三𠯤 |
| WO2021176045A1 (en) | 2020-03-06 | 2021-09-10 | Bayer Aktiengesellschaft | Imidazotriazines acting on cancer via inhibition of cdk12 |
| WO2021176049A1 (en) | 2020-03-06 | 2021-09-10 | Bayer Aktiengesellschaft | Pyrazolopyrazines acting on cancers via inhibition of cdk12 |
-
2023
- 2023-01-06 CN CN202380016568.XA patent/CN118541372A/zh active Pending
- 2023-01-06 WO PCT/EP2023/050208 patent/WO2023135057A1/en not_active Ceased
- 2023-01-06 KR KR1020247026963A patent/KR20240134962A/ko active Pending
- 2023-01-06 JP JP2024541916A patent/JP2025502240A/ja active Pending
- 2023-01-06 EP EP23702959.0A patent/EP4463458A1/en active Pending
- 2023-01-06 IL IL313835A patent/IL313835A/en unknown
- 2023-01-06 US US18/728,291 patent/US20250066370A1/en active Pending
- 2023-01-06 AU AU2023207765A patent/AU2023207765A1/en active Pending
- 2023-01-06 CA CA3246440A patent/CA3246440A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9241939B2 (en) | Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway | |
| KR101626996B1 (ko) | 벤조피란 및 벤족세핀 ｐｉ３ｋ 저해제 화합물 및 이의 사용 방법 | |
| KR20220148847A (ko) | 다브라페닙, erk 억제제, 및 shp2 억제제를 포함하는 삼중 약학적 조합물 | |
| EP4667464A1 (en) | Azolylpyridine pyridazinone amide as sos1 inhibitor | |
| JP2018531983A (ja) | タンパク質分解誘導キメラ化合物ならびにその調製方法および使用方法 | |
| KR20180054657A (ko) | Dna 손상제 및 atr 저해제의 병용물을 사용한 암 치료 방법 | |
| JP2021519783A5 (https=) | ||
| CN105120868A (zh) | 组合治疗 | |
| EP3845531A1 (en) | Substituted pyrazole fused ring derivative, preparation method therefor, and application thereof | |
| JP2023504230A (ja) | Ｐｒｍｔ５阻害剤の組合せ医薬 | |
| RU2010112837A (ru) | Комбинации ингибиторов фосфоинозитид 3-киназы и химиотерапевтических агентов и способы применения | |
| TW202529768A (zh) | 癌症治療的療法 | |
| JP2000159672A (ja) | 硝酸誘発耐性の処置剤 | |
| JP2018510869A (ja) | 置換２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリンを含んでいる組合せ | |
| JP2018509442A (ja) | Ｆｇｆｒ４阻害剤としてのホルミル化ｎ−複素環式誘導体 | |
| CN102958518A (zh) | 磷脂酰肌醇3-激酶抑制剂和抗糖尿病化合物的组合 | |
| CN1511036B (zh) | 包含信号转导抑制剂和埃坡霉素衍生物的联合形式 | |
| KR20210146290A (ko) | 헤테로시클릭 단백질 키나제 억제제를 포함하는 제제 | |
| JP2025502240A5 (https=) | ||
| CN111718349B (zh) | 含氟吡唑并嘧啶化合物和药物组合物及其应用 | |
| CN117355512A (zh) | 杂环衍生物、药物组合物及其在治疗或改善癌症中的用途 | |
| CN105050602A (zh) | 作为pi3激酶抑制剂的吡啶化合物 | |
| US20210369724A1 (en) | Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compounds | |
| CN111718350A (zh) | 吡唑取代的吡唑并嘧啶化合物和药物组合物及其应用 | |
| CN102105148A (zh) | 包含aurora激酶抑制剂和抗肿瘤药的治疗组合 |